Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
Status:
Completed
Trial end date:
2020-09-11
Target enrollment:
Participant gender:
Summary
This is a double blind randomised controlled feasibility study investigating the effect of
postnatal enalapril on cardiovascular function in women who have had preterm pre-eclampsia.
Participants will be randomised to 6 months of enalapril or placebo within 3 days of
delivery. Cardiovascular function will be assessed using serial echocardiography and
biomarkers.